Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial.
Saved in:
| Title: | Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. |
|---|---|
| Authors: | Thompson JA; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom., Kityo C; Joint Clinical Research Centre, Kampala, Uganda., Dunn D; Medical Research Council Clinical Trials Unit at University College London, United Kingdom., Hoppe A; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Division of Infection and Immunity, University College London, United Kingdom., Ndashimye E; Joint Clinical Research Centre, Kampala, Uganda.; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada., Hakim J; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Kambugu A; Infectious Diseases Institute, Makerere University, Kampala, Uganda., van Oosterhout JJ; Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi.; Dignitas International, Zomba, Malawi., Arribas J; IdiPAZ, La Paz Hospital, Madrid, Spain., Mugyenyi P; Joint Clinical Research Centre, Kampala, Uganda., Walker AS; Medical Research Council Clinical Trials Unit at University College London, United Kingdom., Paton NI; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Yong Loo Lin School of Medicine, National University of Singapore. |
| Corporate Authors: | Europe–Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Mar 19; Vol. 68 (7), pp. 1184-1192. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30060027 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Thompson+JA%22">Thompson JA</searchLink>; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kityo+C%22">Kityo C</searchLink>; Joint Clinical Research Centre, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Dunn+D%22">Dunn D</searchLink>; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hoppe+A%22">Hoppe A</searchLink>; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Division of Infection and Immunity, University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ndashimye+E%22">Ndashimye E</searchLink>; Joint Clinical Research Centre, Kampala, Uganda.; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hakim+J%22">Hakim J</searchLink>; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Kambugu+A%22">Kambugu A</searchLink>; Infectious Diseases Institute, Makerere University, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22van+Oosterhout+JJ%22">van Oosterhout JJ</searchLink>; Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi.; Dignitas International, Zomba, Malawi.<br /><searchLink fieldCode="AU" term="%22Arribas+J%22">Arribas J</searchLink>; IdiPAZ, La Paz Hospital, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mugyenyi+P%22">Mugyenyi P</searchLink>; Joint Clinical Research Centre, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Walker+AS%22">Walker AS</searchLink>; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Paton+NI%22">Paton NI</searchLink>; Medical Research Council Clinical Trials Unit at University College London, United Kingdom.; Yong Loo Lin School of Medicine, National University of Singapore. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Europe–Africa+Research+Network+for+Evaluation+of+Second-line+Therapy+%28EARNEST%29+Trial+Team%22">Europe–Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2019 Mar 19; Vol. 68 (7), pp. 1184-1192. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30060027 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciy589 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1184 Titles: – TitleFull: Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thompson JA – PersonEntity: Name: NameFull: Kityo C – PersonEntity: Name: NameFull: Dunn D – PersonEntity: Name: NameFull: Hoppe A – PersonEntity: Name: NameFull: Ndashimye E – PersonEntity: Name: NameFull: Hakim J – PersonEntity: Name: NameFull: Kambugu A – PersonEntity: Name: NameFull: van Oosterhout JJ – PersonEntity: Name: NameFull: Arribas J – PersonEntity: Name: NameFull: Mugyenyi P – PersonEntity: Name: NameFull: Walker AS – PersonEntity: Name: NameFull: Paton NI IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 03 Text: 2019 Mar 19 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 68 – Type: issue Value: 7 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |